[2]
Ansari S. Understanding the Impact of Chronic Obstructive Pulmonary Disease and Intervening to Improve Self-Management in the Context of Multi-morbidity. International journal of integrated care. 2018 Jul 19:18(3):7. doi: 10.5334/ijic.4187. Epub 2018 Jul 19
[PubMed PMID: 30093845]
Level 3 (low-level) evidence
[3]
Kheradmand F, You R, Hee Gu B, Corry DB. Cigarette Smoke and DNA Cleavage Promote Lung Inflammation and Emphysema. Transactions of the American Clinical and Climatological Association. 2017:128():222-233
[PubMed PMID: 28790504]
[4]
Siddharthan T, Pollard SL, Quaderi SA, Rykiel NA, Wosu AC, Alupo P, Barber JA, Cárdenas MK, Chandyo RK, Flores-Flores O, Kirenga B, Miranda JJ, Mohan S, Ricciardi F, Sharma AK, Das SK, Shrestha L, Soares MO, Checkley W, Hurst JR, GECo Study Investigators. Discriminative Accuracy of Chronic Obstructive Pulmonary Disease Screening Instruments in 3 Low- and Middle-Income Country Settings. JAMA. 2022 Jan 11:327(2):151-160. doi: 10.1001/jama.2021.23065. Epub
[PubMed PMID: 35015039]
[5]
Nicolini A, Barbagelata E, Tagliabue E, Colombo D, Monacelli F, Braido F. Gender differences in chronic obstructive pulmonary diseases: a narrative review. Panminerva medica. 2018 Dec:60(4):192-199. doi: 10.23736/S0031-0808.18.03463-8. Epub 2018 Jun 1
[PubMed PMID: 29856178]
Level 3 (low-level) evidence
[6]
Sana A, Somda SMA, Meda N, Bouland C. Chronic obstructive pulmonary disease associated with biomass fuel use in women: a systematic review and meta-analysis. BMJ open respiratory research. 2018:5(1):e000246. doi: 10.1136/bmjresp-2017-000246. Epub 2018 Jan 12
[PubMed PMID: 29387422]
Level 1 (high-level) evidence
[7]
Nagaraj C,Tabeling C,Nagy BM,Jain PP,Marsh LM,Papp R,Pienn M,Witzenrath M,Ghanim B,Klepetko W,Weir EK,Heschl S,Kwapiszewska G,Olschewski A,Olschewski H, Hypoxic vascular response and ventilation/perfusion matching in end-stage COPD may depend on p22phox. The European respiratory journal. 2017 Jul
[PubMed PMID: 28729471]
[8]
Dunham-Snary KJ, Wu D, Sykes EA, Thakrar A, Parlow LRG, Mewburn JD, Parlow JL, Archer SL. Hypoxic Pulmonary Vasoconstriction: From Molecular Mechanisms to Medicine. Chest. 2017 Jan:151(1):181-192. doi: 10.1016/j.chest.2016.09.001. Epub 2016 Sep 16
[PubMed PMID: 27645688]
[9]
Viniol C, Vogelmeier CF. Exacerbations of COPD. European respiratory review : an official journal of the European Respiratory Society. 2018 Mar 31:27(147):. doi: 10.1183/16000617.0103-2017. Epub 2018 Mar 14
[PubMed PMID: 29540496]
[10]
Kobayashi S, Nishimura M, Yamamoto M, Akiyama Y, Miyamoto K, Kawakami Y. Respiratory load compensation during hypercapnic ventilatory response in pulmonary emphysema. Chest. 1994 May:105(5):1399-405
[PubMed PMID: 8181326]
[11]
Inkrott JC. Understanding Hypoxic Drive and the Release of Hypoxic Vasoconstriction. Air medical journal. 2016 Jul-Aug:35(4):210-1. doi: 10.1016/j.amj.2016.03.006. Epub 2016 Jun 3
[PubMed PMID: 27393755]
Level 3 (low-level) evidence
[12]
O'Donnell DE, Banzett RB, Carrieri-Kohlman V, Casaburi R, Davenport PW, Gandevia SC, Gelb AF, Mahler DA, Webb KA. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proceedings of the American Thoracic Society. 2007 May:4(2):145-68
[PubMed PMID: 17494725]
[13]
Ucgun I, Oztuna F, Dagli CE, Yildirim H, Bal C. Relationship of metabolic alkalosis, azotemia and morbidity in patients with chronic obstructive pulmonary disease and hypercapnia. Respiration; international review of thoracic diseases. 2008:76(3):270-4. doi: 10.1159/000131707. Epub 2008 May 8
[PubMed PMID: 18463428]
[14]
Edwards SL. Pathophysiology of acid base balance: the theory practice relationship. Intensive & critical care nursing. 2008 Feb:24(1):28-38; quiz 38-40
[PubMed PMID: 17689248]
[15]
Kreppein U, Litterst P, Westhoff M. [Hypercapnic respiratory failure. Pathophysiology, indications for mechanical ventilation and management]. Medizinische Klinik, Intensivmedizin und Notfallmedizin. 2016 Apr:111(3):196-201. doi: 10.1007/s00063-016-0143-2. Epub 2016 Feb 22
[PubMed PMID: 26902369]
[16]
Schiavo A, Renis M, Polverino M, Iannuzzi A, Polverino F. Acid-base balance, serum electrolytes and need for non-invasive ventilation in patients with hypercapnic acute exacerbation of chronic obstructive pulmonary disease admitted to an internal medicine ward. Multidisciplinary respiratory medicine. 2016:11():23. doi: 10.1186/s40248-016-0063-2. Epub 2016 May 25
[PubMed PMID: 27226896]
[17]
Kayacan O, Beder S, Deda G, Karnak D. Neurophysiological changes in COPD patients with chronic respiratory insufficiency. Acta neurologica Belgica. 2001 Sep:101(3):160-5
[PubMed PMID: 11817264]
[18]
Manca-Di-Villahermosa S, Tedesco M, Lonzi M, Della-Rovere FR, Innocenzi A, Colarieti G, Favarò A, Chamoun GM, Taccone-Gallucci M. Acid-base balance and oxygen tension during dialysis in uremic patients with chronic obstructive pulmonary disease. Artificial organs. 2008 Dec:32(12):973-7. doi: 10.1111/j.1525-1594.2008.00658.x. Epub
[PubMed PMID: 19133027]
[19]
Bardsley G, Pilcher J, McKinstry S, Shirtcliffe P, Berry J, Fingleton J, Weatherall M, Beasley R. Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial. BMC pulmonary medicine. 2018 Oct 3:18(1):157. doi: 10.1186/s12890-018-0720-7. Epub 2018 Oct 3
[PubMed PMID: 30285695]
Level 1 (high-level) evidence
[20]
Austin MA, Wills KE, Blizzard L, Walters EH, Wood-Baker R. Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial. BMJ (Clinical research ed.). 2010 Oct 18:341():c5462. doi: 10.1136/bmj.c5462. Epub 2010 Oct 18
[PubMed PMID: 20959284]
Level 1 (high-level) evidence
[21]
Aubier M, Murciano D, Fournier M, Milic-Emili J, Pariente R, Derenne JP. Central respiratory drive in acute respiratory failure of patients with chronic obstructive pulmonary disease. The American review of respiratory disease. 1980 Aug:122(2):191-9
[PubMed PMID: 6774639]
[22]
Hanson CW 3rd, Marshall BE, Frasch HF, Marshall C. Causes of hypercarbia with oxygen therapy in patients with chronic obstructive pulmonary disease. Critical care medicine. 1996 Jan:24(1):23-8
[PubMed PMID: 8565533]
[23]
Raherison C, Ouaalaya EH, Bernady A, Casteigt J, Nocent-Eijnani C, Falque L, Le Guillou F, Nguyen L, Ozier A, Molimard M. Comorbidities and COPD severity in a clinic-based cohort. BMC pulmonary medicine. 2018 Jul 16:18(1):117. doi: 10.1186/s12890-018-0684-7. Epub 2018 Jul 16
[PubMed PMID: 30012144]
[24]
Culver BH. Assessment of severity and prognosis in COPD: moving beyond percent of predicted. The European respiratory journal. 2018 Aug:52(2):. pii: 1801005. doi: 10.1183/13993003.01005-2018. Epub 2018 Aug 2
[PubMed PMID: 30072543]
[25]
Sadatsafavi M, Ghanbarian S, Adibi A, Johnson K, FitzGerald JM, Flanagan W, Bryan S, Sin D, Canadian Respiratory Research Network. Development and Validation of the Evaluation Platform in COPD (EPIC): A Population-Based Outcomes Model of COPD for Canada. Medical decision making : an international journal of the Society for Medical Decision Making. 2019 Feb:39(2):152-167. doi: 10.1177/0272989X18824098. Epub 2019 Jan 24
[PubMed PMID: 30678520]
Level 1 (high-level) evidence